Trial Profile
A Retrospective study to evaluate hesitancy towards Adalimumab treatment in patients enrolled in the Nurse Care Management Program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Inflammatory bowel diseases; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2017 New trial record